A nanocarrier that can deliver siRNA into the lungs is investigated for the treatment of severe asthma and other lung diseases.
Conserved elements in viral genomes may provide targets for broad-spectrum drugs
RNA elements that are found in the genomes of numerous representatives within the same virus family provide new opportunities to expand the repertoire of targets for the development of antiviral therapy.
What cells does SARS-CoV-2 attack?
A collaborative team of German scientists identify which lung cells are susceptible to SARS-CoV-2 and why infection severity varies in different demographics.
Mouse study shows engineered virus could block coronavirus infections
Scientists engineer a virus known to be be harmless to humans to stimulate an immune response against the coronavirus family in mice.
Obituary: William “Bill” Frankland, the Grandfather of Allergy
Advanced Science News takes a look at the life of Dr. Bill Frankland, pioneer in allergy medicine and inventor of the pollen count, who passed away on April 2, 2020.
Seeking connection through art in a pandemic
In facing a pandemic of this magnitude, coming together and seeking connection is more important than ever before.
From the Wiley archives: Preparing for emergencies
With the current COVID-19 pandemic ongoing, we were curious how Wiley journals were publishing the latest research 100 years ago, when another, and worse, pandemic ravaged the world.
Supercomputer simulates molecular model of SARS-CoV-2
Researchers at UT Austin hope their computer model of COVID-19 can help other scientists in developing new drugs against the virus.
Greenhouse gas emissions show sharp decline due to pandemic
Around the world, cities and regions are showing significant drops in pollution and greenhouse gas levels.
A nanoreactor to simplify pharmaceutical manufacturing
A new nanoreactor integrates multiple catalysts to carry out multiple reactions in the same pot, streamlining the production of fine chemicals—including urgently needed medicines.